Digital Exclusives
Price transparency is a mainstay of most markets. It has been touted as a way to reduce health care spending by enabling a new breed of cost-conscious consumers to comparison shop for care. A new JAMA study suggests that it might not be that simple. Janet Weiner of the Leonard Davis Institute of Health Economics explains.
Ari Friedman and Janet Weiner of the Leonard Davis Institute of Health Economics discuss drug prices, their rising costs, and the policy changes that could provide solutions.
